PCSA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

PCSA

46.0
AI Score
VS
PCSA Wins

CLYM

32.7
AI Score

Investment Advisor Scores

PCSA

46score
Recommendation
HOLD

CLYM

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PCSA CLYM Winner
Net Income -27.42M -27.22M CLYM
Operating Income -27.53M -30.57M PCSA
ROE -367.1% -11.4% CLYM
ROA -318.2% -11.1% CLYM
Total Assets 8.62M 246.29M CLYM
Cash 6.50M 44.11M CLYM
Current Ratio 8.40 31.45 CLYM

Relative Price Performance (Last 90 Days)

PCSA 1M: -27.5% · 3M: -18.9% CLYM 1M: +35.4% · 3M: +58.4%

Current Technical Phase

PCSA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.6%), weak momentum, RSI 43

RSI (14): 42.8 · Price: $2.08

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.1% over 20 days), RSI 74

RSI (14): 74.1 · Price: $17.28

Fundamentals Snapshot

Metric PCSA CLYM
Market Cap
Forward P/E -0.6 -16.4
Trailing P/E 3.3
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS 0.65 -0.80
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCSA is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.